IMUNON Presents PLACCINE Data at Vaccine Technology Summit 2023
22 mars 2023 08h00 HE
|
Imunon, Inc.
Chief Science Officer describes compelling preclinical data supporting continued development of PLACCINE as a differentiated, next-generation vaccine modality LAWRENCEVILLE, N.J., March 22, 2023 ...
IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
14 nov. 2022 08h00 HE
|
Imunon, Inc.
Conference Call Today at 11:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing...